CPT2

UniProt ID: P23786
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

Carnitine O-palmitoyltransferase 2 (CPT2, EC 2.3.1.21) is a mitochondrial enzyme of the carnitine/choline acetyltransferase family that is peripherally associated with the matrix side of the mitochondrial inner membrane. It catalyzes the final, matrix-side step of the carnitine shuttle, regenerating long-chain acyl-CoA from imported acylcarnitine (long-chain acylcarnitine + CoA to long-chain acyl-CoA + L-carnitine), the reverse-direction reaction to CPT1. This reconstitutes the acyl-CoA pool inside the matrix so that long-chain fatty acids can enter mitochondrial beta-oxidation; CPT2 is therefore essential for the mitochondrial uptake and oxidation of long-chain fatty acids. The enzyme is active with medium-chain (C8-C12) and long-chain (C14-C18) acyl-CoA esters. Loss of CPT2 function causes carnitine palmitoyltransferase II deficiency, an autosomal recessive disorder of long-chain fatty acid oxidation with lethal neonatal, severe infantile hepatocardiomuscular, and common adult myopathic (exercise/fever/fasting-triggered rhabdomyolysis) forms; thermolabile variants predispose to influenza-associated encephalopathy.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005739 mitochondrion
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (PAN-GO) inference that CPT2 is active in the mitochondrion. Correct but general; CPT2 is more precisely at the mitochondrial inner membrane (matrix side). Accept as a correct broad localization.
Reason: CPT2 is a well-established mitochondrial enzyme. The IBA reflects the conserved mitochondrial localization across the ortholog set and is consistent with all experimental data.
Supporting Evidence:
PMID:1988962
an inner mitochondrial membrane enzyme that plays a major role in
GO:0004095 carnitine O-palmitoyltransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of the core molecular function, carnitine O-palmitoyltransferase (EC 2.3.1.21). This is the defining activity of CPT2 and is directly supported by human enzyme assays.
Reason: Well-supported core function; the IBA is at the correct level of specificity and agrees with direct experimental evidence in human CPT2.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0006635 fatty acid beta-oxidation
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference that CPT2 is involved in fatty acid beta-oxidation. By regenerating matrix acyl-CoA, CPT2 is required for long-chain fatty acids to enter beta-oxidation. Core biological process.
Reason: The carnitine shuttle step catalyzed by CPT2 is an obligatory prerequisite for mitochondrial long-chain fatty acid beta-oxidation; this is confirmed both by disease phenotypes and enzyme studies.
Supporting Evidence:
PMID:25578732
Once inside the mitochondrial matrix, CPT2 generates acyl-CoAs from acyl-carnitines to initiate the beta-oxidation of long chain fatty acids to acetyl-CoA
GO:0004095 carnitine O-palmitoyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (multi-method, includes Rhea RHEA:12661 / EC 2.3.1.21) assignment of carnitine O-palmitoyltransferase activity. Correct core molecular function.
Reason: Matches the experimentally verified catalytic activity of human CPT2 (RHEA:12661, EC 2.3.1.21).
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0005743 mitochondrial inner membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Subcellular-location mapping (UniProt SL-0168) to mitochondrial inner membrane. Correct; CPT2 is a peripheral inner-membrane protein on the matrix side.
Reason: Agrees with the UniProt-curated subcellular location and with the topology features (intramembrane 179-208; matrix-facing catalytic domain).
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Mitochondrion inner membrane; Peripheral membrane
GO:0008458 carnitine O-octanoyltransferase activity
IEA
GO_REF:0000116
ACCEPT
Summary: Rhea-based (RHEA:17177) electronic assignment of carnitine O-octanoyltransferase activity (C8 acyl-CoA). CPT2 is experimentally active toward medium-chain (C8-C12) acyl-CoAs, so this is a genuine, if secondary, activity of the same catalytic site.
Reason: Human CPT2 has measurable activity with octanoyl-CoA (medium chain); this reflects the broad chain-length specificity of the single carnitine acyltransferase active site rather than a distinct enzyme, but the activity is real and experimentally documented.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0015909 long-chain fatty acid transport
IEA
GO_REF:0000117
MODIFY
Summary: ARBA machine-learning assignment of long-chain fatty acid transport. CPT2 does not itself transport fatty acids or acylcarnitines across the membrane (that is done by CPT1 plus the carnitine/acylcarnitine translocase SLC25A20); CPT2 is the matrix-side enzyme that regenerates acyl-CoA. The functional essence (enabling mitochondrial long-chain FA import for oxidation) is sound but the transport term mis-describes the mechanism.
Reason: CPT2 is an acyltransferase, not a transporter. Its contribution to long-chain fatty acid uptake is indirect (completing the carnitine shuttle). The more accurate terms are the carnitine shuttle and fatty acid beta-oxidation processes it enables.
Supporting Evidence:
PMID:25578732
Once inside the mitochondrial matrix, CPT2 generates acyl-CoAs from acyl-carnitines to initiate the beta-oxidation of long chain fatty acids to acetyl-CoA
GO:0016746 acyltransferase activity
IEA
GO_REF:0000002
MODIFY
Summary: InterPro2GO (IPR000542, carnitine acyltransferase) mapping to the general parent term acyltransferase activity. Correct but far too general given that the specific carnitine O-palmitoyltransferase activity (GO:0004095) is directly established for CPT2.
Reason: An uninformative high-level term; the specific molecular function is known and experimentally supported.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: High-throughput affinity-capture (BioPlex) interactome screen. Bare protein binding is uninformative and does not describe a specific molecular function of CPT2. CPT2 appears only in the large-scale interaction dataset.
Reason: Per curation guidelines, bare GO:0005515 protein binding from high-throughput interactome data adds no functional information and should not be treated as a core or informative annotation. Retained (not removed) as it derives from experimental IPI evidence.
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities and disease networks.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Binary yeast two-hybrid interactome (HuRI); partners recorded in UniProt include CYSRT1 (A8MQ03) and OTX1 (P32242). Bare protein binding is uninformative about CPT2 molecular function.
Reason: Bare protein binding from a high-throughput binary interactome screen does not describe a specific, biologically meaningful molecular function of CPT2. Retained as experimental IPI evidence rather than removed.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Cell-specific proteome-scale interactome (BioPlex, HCT116/293T); interaction with MCUR1 (Q96AQ8) recorded. Bare protein binding is uninformative.
Reason: As with the other interactome-derived protein binding annotations, this adds no specific functional information for CPT2. Retained as experimental IPI evidence.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-transfer (Ensembl Compara, from mouse P52825) assignment placing the active enzyme on the matrix side. Consistent with the UniProt topology (matrix-facing catalytic domain, matrix side of the inner membrane).
Reason: CPT2's catalytic domain faces the mitochondrial matrix; is_active_in mitochondrial matrix accurately reflects where catalysis occurs, complementing the inner-membrane location.
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Mitochondrion inner membrane; Peripheral membrane
GO:0006853 carnitine shuttle
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-transfer assignment of the carnitine shuttle process. CPT2 catalyzes the final matrix-side step of the shuttle, regenerating acyl-CoA. Core biological process.
Reason: CPT2 is a defining member of the carnitine shuttle; this is the process most specifically describing its physiological role.
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Reconverts
GO:0120162 positive regulation of cold-induced thermogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Ortholog-transfer (from mouse) of a role in positive regulation of cold-induced thermogenesis. Based on adipose-specific Cpt2 knockout mice that become hypothermic after cold challenge and fail to upregulate thermogenic genes in brown adipose tissue. This is a genuine but tissue-specific (BAT), downstream organismal consequence of CPT2-dependent fatty acid oxidation, not the core enzymatic function.
Reason: The phenotype is real (mouse adipose Cpt2 loss impairs cold-induced thermogenesis) but it is a context-dependent physiological role in a specific tissue, downstream of the enzyme's fatty acid beta-oxidation function. Keep as non-core.
Supporting Evidence:
PMID:25578732
CPT2(A-/-) mice became hypothermic after an
PMID:25578732
adipose tissue fatty acid oxidation is not only required for acute cold adaptation, but also for the induction of thermogenic genes in BAT
GO:0006853 carnitine shuttle
TAS
Reactome:R-HSA-200425
ACCEPT
Summary: Reactome (Carnitine shuttle pathway) traceable-author-statement assignment. CPT2 catalyzes the matrix-side acylcarnitine-to-acyl-CoA step of this pathway. Core process, correctly attributed.
Reason: Directly and authoritatively describes CPT2's role in the carnitine shuttle.
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Reconverts
GO:0006635 fatty acid beta-oxidation
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway (UPA00659, fatty acid beta-oxidation) mapping. CPT2 is required for long-chain fatty acids to enter beta-oxidation. Core process.
Reason: Consistent with the curated UniProt PATHWAY assignment (fatty acid beta-oxidation) and with all experimental data.
Supporting Evidence:
PMID:25578732
Once inside the mitochondrial matrix, CPT2 generates acyl-CoAs from acyl-carnitines to initiate the beta-oxidation of long chain fatty acids to acetyl-CoA
GO:0005739 mitochondrion
IDA
GO_REF:0000052
ACCEPT
Summary: Direct immunofluorescence (Human Protein Atlas) localization to the mitochondrion. Correct, though more precisely the inner membrane / matrix.
Reason: Direct experimental localization consistent with all other evidence. Broad but correct.
Supporting Evidence:
PMID:1988962
an inner mitochondrial membrane enzyme that plays a major role in
GO:0016406 carnitine O-acyltransferase activity
EXP
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Experimental (substrate profiling of human CPT2) support for carnitine O-acyltransferase activity, the parent term covering both the palmitoyl (C16) and octanoyl (C8) activities. Accurate.
Reason: Directly supported by enzyme assays showing CPT2 acts on medium- and long-chain acyl-CoAs. Correct, if somewhat general relative to the more specific GO:0004095.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0016406 carnitine O-acyltransferase activity
EXP
PMID:7711730
Carnitine palmitoyltransferase II deficiency: structure of t...
ACCEPT
Summary: Experimental support (transfection/COS-cell CPT II activity assays in the context of disease-mutation characterization) for carnitine O-acyltransferase activity of CPT2. Accurate parent-level MF.
Reason: The study measured CPT II catalytic activity in cells expressing wild-type and mutant CPT2, confirming carnitine acyltransferase activity for the gene product.
Supporting Evidence:
PMID:7711730
Transfection experiments in COS cells demonstrated that both mutations drastically depressed the catalytic activity of CPT II.
GO:0004095 carnitine O-palmitoyltransferase activity
EXP
PMID:24780397
Functional analysis of iPSC-derived myocytes from a patient ...
ACCEPT
Summary: Experimental support (CPT II-deficient patient iPSC-derived myocytes; accumulation of C16 palmitoylcarnitine reflecting loss of the palmitoyltransferase step) for carnitine O-palmitoyltransferase activity. Core molecular function.
Reason: The disease-model data (C16 acylcarnitine accumulation with impaired CPT2) confirm the carnitine O-palmitoyltransferase activity of human CPT2.
Supporting Evidence:
PMID:24780397
CPT II-deficient myocytes accumulated more palmitoylcarnitine (C16)
GO:0008458 carnitine O-octanoyltransferase activity
EXP
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Experimental support for octanoyl-CoA (C8, medium chain) activity of human CPT2 from the substrate-specificity study. Genuine secondary activity of the same catalytic site.
Reason: Human CPT2 has measurable medium-chain (C8) carnitine acyltransferase activity; experimentally documented.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: High-throughput proteomic identification of CPT2 in the high-confidence human mitochondrial proteome (MitoCoP). Confirms mitochondrial localization.
Reason: Consistent with all other localization evidence; a correct, if broad, mitochondrial assignment from a rigorous proteomic dataset.
Supporting Evidence:
PMID:34800366
mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
GO:0001676 long-chain fatty acid metabolic process
IDA
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Direct experimental support that CPT2 participates in long-chain fatty acid metabolism, from its activity toward long-chain (C14-C18) acyl-CoAs. Accurate process annotation.
Reason: CPT2's substrate profile and its obligatory role in mitochondrial long-chain fatty acid oxidation directly support this process.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0004095 carnitine O-palmitoyltransferase activity
IDA
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Direct enzyme assay (human CPT2 expressed in yeast) of carnitine O-palmitoyltransferase activity toward long-chain acyl-CoAs. This is the primary experimental basis for the core molecular function.
Reason: Strongest, most specific experimental support for the defining catalytic activity of CPT2.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0006635 fatty acid beta-oxidation
IDA
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Direct experimental support that CPT2 functions in fatty acid beta-oxidation, based on demonstration that CPT2 handles the medium/long-chain acyl-CoAs that feed beta-oxidation. Core process.
Reason: CPT2's role in regenerating matrix acyl-CoA is an obligatory step enabling beta-oxidation, directly supported by its substrate specificity and by disease phenotypes.
Supporting Evidence:
PMID:20538056
reflect the potentially toxic
GO:0009437 carnitine metabolic process
IDA
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
ACCEPT
Summary: Direct experimental support that CPT2 participates in carnitine metabolism, as it interconverts acylcarnitine and free carnitine during the shuttle. Accurate.
Reason: CPT2 consumes acylcarnitine and releases free L-carnitine, directly acting on carnitine-containing metabolites; supported by the substrate/product profiling.
Supporting Evidence:
PMID:20538056
CPT2 is able to reverse its physiological mechanism for
GO:0016746 acyltransferase activity
IDA
PMID:20538056
Carnitine palmitoyltransferase 2: New insights on the substr...
MODIFY
Summary: Direct experimental support at the general acyltransferase level. As with the InterPro IEA, this parent term is correct but far less informative than the specific carnitine O-palmitoyltransferase activity established in the same study.
Reason: Too general; the specific molecular function (carnitine O-palmitoyltransferase) is directly demonstrated in this very paper and should be used instead.
Supporting Evidence:
PMID:20538056
CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters
GO:0120162 positive regulation of cold-induced thermogenesis
ISS
PMID:25578732
Adipose fatty acid oxidation is required for thermogenesis a...
KEEP AS NON CORE
Summary: Sequence/ortholog-based (ISS from mouse P52825) transfer of a role in positive regulation of cold-induced thermogenesis, grounded in adipose-specific Cpt2 knockout mice that become hypothermic and fail to induce BAT thermogenic genes. Genuine but tissue-specific downstream physiological role.
Reason: Real phenotype in mouse adipose tissue, but a context-dependent organismal consequence downstream of CPT2's fatty acid beta-oxidation function rather than its core molecular activity. Keep as non-core.
Supporting Evidence:
PMID:25578732
CPT2(A-/-) mice became hypothermic after an
PMID:25578732
adipose tissue fatty acid oxidation is not only required for acute cold adaptation, but also for the induction of thermogenic genes in BAT
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-1989773
ACCEPT
Summary: Reactome traceable-author-statement localization to the mitochondrial inner membrane. Correct; CPT2 is a peripheral inner-membrane protein on the matrix side.
Reason: Matches the curated UniProt subcellular location and topology.
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Mitochondrion inner membrane; Peripheral membrane
GO:0005743 mitochondrial inner membrane
TAS
Reactome:R-HSA-200410
ACCEPT
Summary: Reactome (CPT2 converts acylcarnitine to acyl-CoA) traceable-author-statement localization to the mitochondrial inner membrane. Correct core localization.
Reason: Matches curated UniProt localization; this Reactome reaction is exactly the matrix-side step CPT2 catalyzes.
Supporting Evidence:
file:human/CPT2/CPT2-uniprot.txt
Mitochondrion inner membrane; Peripheral membrane
GO:0004095 carnitine O-palmitoyltransferase activity
NAS
PMID:1988962
cDNA cloning, sequence analysis, and chromosomal localizatio...
ACCEPT
Summary: Non-traceable author statement (original cloning paper describing CPT2 as palmitoyl-CoA:L-carnitine O-palmitoyltransferase, EC 2.3.1.21). Correct core molecular function, later confirmed experimentally.
Reason: The defining catalytic activity of CPT2, asserted in the founding cloning study and subsequently verified by direct assay.
Supporting Evidence:
PMID:1988962
an inner mitochondrial membrane enzyme that plays a major role in
GO:0005743 mitochondrial inner membrane
NAS
PMID:1988962
cDNA cloning, sequence analysis, and chromosomal localizatio...
ACCEPT
Summary: Non-traceable author statement from the cloning paper describing CPT2 as an inner mitochondrial membrane enzyme. Correct core localization.
Reason: Consistent with curated UniProt subcellular location and with experimental proteomic/imaging localization.
Supporting Evidence:
PMID:1988962
an inner mitochondrial membrane enzyme that plays a major role in

Core Functions

Carnitine O-palmitoyltransferase (EC 2.3.1.21) activity on the matrix side of the mitochondrial inner membrane, catalyzing the final step of the carnitine shuttle to regenerate long-chain acyl-CoA from imported acylcarnitine (long-chain acylcarnitine + CoA to long-chain acyl-CoA + L-carnitine), thereby enabling mitochondrial long-chain fatty acid beta-oxidation.

Supporting Evidence:
  • PMID:20538056
    CPT2 is active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters

Participation in mitochondrial long-chain fatty acid beta-oxidation by regenerating the matrix acyl-CoA pool, an obligatory step that allows imported long-chain fatty acids to be oxidized to acetyl-CoA.

Supporting Evidence:
  • PMID:25578732
    Once inside the mitochondrial matrix, CPT2 generates acyl-CoAs from acyl-carnitines to initiate the beta-oxidation of long chain fatty acids to acetyl-CoA

References

Loading supporting content…

Download this section (compressed HTML)

Deep Research

Falcon

(CPT2-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(CPT2-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)